IVF PE Ratio & Valuation,Is IVF Overvalued — Intellectia
IVF Relative Valuation
IVF's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IVF is overvalued; if below, it's undervalued.
Historical Valuation
INVO Fertility Inc(IVF) is now in theFairzone, suggesting that its currentforward PSratio of0.34is consideredFairlycompared with the five-year average of-0.65.The fair price ofINVO Fertility Inc(IVF)is between1.28to2.34according to relative valuation methord.
Relative Value
Fair Zone
1.28-2.34
Current Price：1.34
Fair
-0.06
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
INVO Fertility Inc. (IVF) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-0.68
EV/EBIT
INVO Fertility Inc. (IVF) has a current EV/EBIT of -0.68. The 5-year average EV/EBIT is -1.51. The thresholds are as follows: Strongly Undervalued below -2.91, Undervalued between -2.91 and -2.21, Fairly Valued between -0.81 and -2.21, Overvalued between -0.81 and -0.11, and Strongly Overvalued above -0.11. The current Forward EV/EBIT of -0.68 falls within the Overvalued range.
0.34
PS
INVO Fertility Inc. (IVF) has a current PS of 0.34. The 5-year average PS is 0.42. The thresholds are as follows: Strongly Undervalued below 0.08, Undervalued between 0.08 and 0.25, Fairly Valued between 0.58 and 0.25, Overvalued between 0.58 and 0.75, and Strongly Overvalued above 0.75. The current Forward PS of 0.34 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
INVO Fertility Inc. (IVF) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
INVO Fertility Inc. (IVF) has a current P/FCF of 0.00. The 5-year average P/FCF is -0.05. The thresholds are as follows: Strongly Undervalued below -0.19, Undervalued between -0.19 and -0.12, Fairly Valued between 0.03 and -0.12, Overvalued between 0.03 and 0.10, and Strongly Overvalued above 0.10. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
INVO Fertility Inc (IVF) has a current Price-to-Book (P/B) ratio of -0.30. Compared to its 3-year average P/B ratio of -0.38 , the current P/B ratio is approximately -20.42% higher. Relative to its 5-year average P/B ratio of -0.38, the current P/B ratio is about -20.42% higher. INVO Fertility Inc (IVF) has a Forward Free Cash Flow (FCF) yield of approximately -306.49%. Compared to its 3-year average FCF yield of -251.56%, the current FCF yield is approximately 21.84% lower. Relative to its 5-year average FCF yield of -251.56% , the current FCF yield is about 21.84% lower.
-0.30
P/B
Median3y
-0.38
Median5y
-0.38
-306.49
FCF Yield
Median3y
-251.56
Median5y
-251.56
Competitors Valuation Multiple
The average P/S ratio for IVF's competitors is 0.48, providing a benchmark for relative valuation. INVO Fertility Inc Corp (IVF) exhibits a P/S ratio of 0.34, which is -28.77% above the industry average. Given its robust revenue growth of 22.60%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IVF decreased by 99.43% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -113.78 to -150.51.
The secondary factor is the Revenue Growth, contributed 22.60%to the performance.
Overall, the performance of IVF in the past 1 year is driven by Margin Expansion. Which is more sustainable.
Is INVO Fertility Inc (IVF) currently overvalued or undervalued?
INVO Fertility Inc(IVF)is now in theFairzone, suggesting that its currentforward PSratio of 0.34is consideredFairlycompared with the five-year average of-0.65.The fair price of INVO Fertility Inc(IVF)is between1.28to2.34according to relative valuation methord.
What is INVO Fertility Inc (IVF) fair value?
IVF's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of INVO Fertility Inc (IVF) is between 1.28to2.34 according to relative valuation methord.
How does IVF's valuation metrics compare to the industry average?
The average P/S ratio for IVF's competitors is 0.48, providing a benchmark for relative valuation. INVO Fertility Inc Corp (IVF) exhibits a P/S ratio of 0.34, which is -28.77% above the industry average. Given its robust revenue growth of 22.60%, this premium appears sustainable.
What is the current P/B ratio for INVO Fertility Inc (IVF) as of Dec 15 2025?
As of Dec 15 2025, INVO Fertility Inc (IVF) has a P/B ratio of -0.30. This indicates that the market values IVF at -0.30 times its book value.
What is the current FCF Yield for INVO Fertility Inc (IVF) as of Dec 15 2025?
As of Dec 15 2025, INVO Fertility Inc (IVF) has a FCF Yield of -306.49%. This means that for every dollar of INVO Fertility Inc’s market capitalization, the company generates -306.49 cents in free cash flow.
What is the current Forward P/E ratio for INVO Fertility Inc (IVF) as of Dec 15 2025?
As of Dec 15 2025, INVO Fertility Inc (IVF) has a Forward P/E ratio of -0.06. This means the market is willing to pay $-0.06 for every dollar of INVO Fertility Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for INVO Fertility Inc (IVF) as of Dec 15 2025?
As of Dec 15 2025, INVO Fertility Inc (IVF) has a Forward P/S ratio of 0.34. This means the market is valuing IVF at $0.34 for every dollar of expected revenue over the next 12 months.
